- Investigator
- Francesco Franchi
- Ages
- 18 Years - N/A
- Sexes
- All
Clinical trials
-
The ABCD-Gene Prospective Study -
Selatogrel Outcome Study in suspected Acute Myocardial Infarction (SOS-AMI) - Investigator
- Francesco Franchi
- Ages
- 18 Years - N/A
- Sexes
- All
-
A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis (PFI) (Also Known as Ledderhose Disease) - Investigators
- John S Anderson, Jason A Piraino
- Ages
- 18 Years - N/A
- Sexes
- All
-
EVOLVE-MI - Investigator
- Francesco Franchi
- Ages
- 18 Years - N/A
- Sexes
- All
-
SWAP 7 - Investigator
- Francesco Franchi
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
ABCD Gene Substudy - Investigator
- Francesco Franchi
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home 鈥� a multi-center randomized controlled trial - Ages
- 30 Years - NA Years
- Sexes
- All
-
Real-time and long-term effects of medical marijuana on older adults with chronic pain; A prospective cohort study - Ages
- 50 Years - N/A
- Sexes
- All
-
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis - Ages
- 18 Years - 75 Years
- Sexes
- All
-
A Phase 2/3, Randomized, Controlled, Masked, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Two Doses of AGTC-501, a Recombinant Adeno-associated Virus Vector Expressing RPGR (rAAV2tYF-GRK1-RPGR), Compared to an Untreated Control - Investigator
- Sandeep Grover
- Ages
- 12 Years - 50 Years
- Sexes
- Male